Evidence map›Paper›PMID 30151646›Full record

ArticleMolecular imaging and biology2019

Optical Redox Imaging of Lonidamine Treatment Response of Melanoma Cells and Xenografts.

He N Xu, Min Feng, Kavindra Nath, David Nelson, Jeff Roman, Huaqing Zhao, Zhenwu Lin, Jerry Glickson, Lin Z Li

Open access · greenAbstract read
In one paragraph

Article in Molecular imaging and biology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
2.0field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 19 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Passage dependence of NADH redox status and reactive oxygen species levelTranslational breast cancer research : a journal focusing on translational research in breast cancer · 2024
    Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Commemorating Britton Chance.Molecular imaging and biology · 2019
    Article
  16. Article
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 1 country.

He N XuDepartment of Radiology, University of Pennsylvania, Philadelphia, PA, USA. hexu2@pennmedicine.upenn.edu.ORCID 0000-0001-5127-2629
Min FengDepartment of Radiology, University of Pennsylvania, Philadelphia, PA, USA.
Kavindra NathDepartment of Radiology, University of Pennsylvania, Philadelphia, PA, USA.
David NelsonDepartment of Radiology, University of Pennsylvania, Philadelphia, PA, USA.
Jeff RomanDepartment of Radiology, University of Pennsylvania, Philadelphia, PA, USA.
Huaqing ZhaoDepartment of Clinical Sciences, Temple University School of Medicine, Philadelphia, PA, USA.
Zhenwu LinDepartment of Radiology, University of Pennsylvania, Philadelphia, PA, USA.
Jerry GlicksonDepartment of Radiology, University of Pennsylvania, Philadelphia, PA, USA.
Lin Z LiDepartment of Radiology, University of Pennsylvania, Philadelphia, PA, USA. linli@pennmedicine.upenn.edu.
University of Pennsylvania · USJohnson Foundation · USTranslational Therapeutics (United States) · USTemple University · US

Funding

Systemic Chemotherapy of Melanoma: NMR Studies of Lonidamine & N-Mustard ActivityR01CA129544 · NCI · UNIVERSITY OF PENNSYLVANIA · PI GLICKSON, JERRY D · 2009 to 2016
$3.2M
Redox imaging for breast cancer prognosisR01CA191207 · NCI · UNIVERSITY OF PENNSYLVANIA · PI LI, LIN Z · 2015 to 2019
$3.2M
Mechanism of Activity of LonidamineR01CA172820 · NCI · UNIVERSITY OF PENNSYLVANIA · PI GLICKSON, JERRY D · 2013 to 2017
$2.8M
Imaging Mitochondrial Redox States In Vivo by Hyperpolarized MRR01CA155348 · NCI · UNIVERSITY OF PENNSYLVANIA · PI LI, LIN Z · 2011 to 2015
$1.9M
NCI NIH HHS R01 CA129544NCI NIH HHS R01 CA155348NCI NIH HHS R01 CA172820NCI NIH HHS R01 CA191207
6 · The paper itself

Abstract

purposeFluorescence of co-enzyme reduced nicotinamide adenine dinucleotide (NADH) and oxidized flavoproteins (Fp) provides a sensitive measure of the mitochondrial redox state and cellular metabolism. By imaging NADH and Fp, we investigated the utility of optical redox imaging (ORI) to monitor cellular metabolism and detect early metabolic response to cancer drugs. PROCEDURES: We performed ORI of human melanoma DB-1 cells in culture and DB-1 mouse xenografts to detect the redox response to lonidamine (LND) treatment.

resultsFor cultured cells, LND treatment for 45 min significantly lowered NADH levels with no significant change in Fp, resulting in a significant increase in the Fp redox ratio (Fp/(NADH+Fp)); 3-h prolonged treatment led to a decrease in NADH and an increase in Fp and a more oxidized redox state compared to control. Significant decrease in the mitochondrial redox capacity of LND-treated cells was observed for the first time. For xenografts, 45-min LND treatment resulted in a significant reduction of NADH content, no significant changes in Fp content, and a trend of increase in the Fp redox ratio. Intratumor redox heterogeneity was observed in both control and LND-treated groups.

conclusionOur results support the utility of ORI for evaluating cellular metabolism and monitoring early metabolic response to cancer drugs.

Indexed as

Optical ImagingAnimalsCell Line, TumorElectron TransportHeterograftsHumansIndazolesMelanomaMice, NudeMitochondriaMitochondrial Uncoupling ProteinsOxidation-ReductionIndazoleslonidamineMitochondrial Uncoupling ProteinsDMSOEarly detectionFADFlavoproteinsMitochondriaNADHOptical imagingRedox ratio

Identifiers

PMID30151646
PMCPMC6525077
OpenAlexW2889059013

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.